Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESS Effective Date: April 29, 2010 Form: S-3...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
As filed with the Securities and Exchange Commission on April 16, 2010 Registration No. 333- ...
Table of Contents As filed with the Securities and Exchange Commission on April 16, 2010. Registration...
CombinatoRx, Incorporated (NASDAQ: CRXX) today announced that preclinical data on its discovery of novel synergistic drug...
CombinatoRx, Incorporated (NASDAQ: CRXX) today announced the publication of new preclinical data in BLOOD, The Journal of the...
CALGARY, Alberta, March 26, 2010 (GLOBE NEWSWIRE) -- Liberty Analytics Co., a leading provider of large, small- and micro-cap independent...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d...
CombinatoRx, Incorporated (NASDAQ: CRXX) today reported financial results for the fourth quarter and year-ended December 31, 2009...
CombinatoRx, Incorporated (NASDAQ: CRXX) today announced that it will report financial results for the fourth quarter and year...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.